tadalafil has been researched along with ethinyl estradiol in 1 studies
Studies (tadalafil) | Trials (tadalafil) | Recent Studies (post-2010) (tadalafil) | Studies (ethinyl estradiol) | Trials (ethinyl estradiol) | Recent Studies (post-2010) (ethinyl estradiol) |
---|---|---|---|---|---|
1,742 | 392 | 1,089 | 9,070 | 1,566 | 1,732 |
Protein | Taxonomy | tadalafil (IC50) | ethinyl estradiol (IC50) |
---|---|---|---|
Solute carrier family 22 member 2 | Homo sapiens (human) | 2.2 | |
Bile salt export pump | Homo sapiens (human) | 10 | |
Estrogen receptor | Homo sapiens (human) | 0.0035 | |
Glucocorticoid receptor | Homo sapiens (human) | 1.71 | |
Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 1.71 | |
Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 0.959 | |
Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 5.678 | |
Androgen receptor | Rattus norvegicus (Norway rat) | 4.8812 | |
Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 1.71 | |
Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 1.71 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.959 | |
Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 1.71 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.054 | |
Sulfotransferase 1A1 | Homo sapiens (human) | 0.02 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.559 | |
Aldehyde oxidase | Homo sapiens (human) | 0.57 | |
Nuclear receptor subfamily 1 group I member 3 | Homo sapiens (human) | 3 | |
Estrogen receptor beta | Homo sapiens (human) | 0.0129 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
1 other study(ies) available for tadalafil and ethinyl estradiol
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |